Primary immunodeficiency and the microbiome

Area of Science:

• Immunology
• Microbiology
• Gastroenterology

Background:

• Primary immunodeficiency diseases (PIDs) are a diverse group of genetic disorders affecting the immune system.
• The gut microbiome plays a critical role in maintaining host immune homeostasis, particularly in the intestine.
• Imbalances in the diet-microbiota-host-immunity axis, characterized by loss of microbial diversity and dysbiosis, are implicated in PID manifestations.

Purpose of the Study:

• To review the current understanding of the relationship between the microbiota and clinical manifestations in patients with primary immunodeficiency.
• To explore the role of microbial dysbiosis in inflammatory processes within PID.
• To discuss potential therapeutic strategies targeting the microbiome in PID.

Main Methods:

• Literature review of studies on the gut microbiome in primary immunodeficiency diseases.
• Analysis of the impact of microbial dysbiosis on immune dysregulation and inflammation in PID.
• Synthesis of current research on therapeutic interventions related to the microbiome in PID.

Main Results:

• Data suggests that alterations in microbial diversity and dysbiosis are associated with clinical manifestations and complications in PID.
• The microbiome appears crucial for maintaining intestinal immune control, and its imbalance contributes to inflammatory processes.
• While the link between the microbiome and humoral immunodeficiency is recognized, its therapeutic potential in PID is an active area of investigation.

Conclusions:

• The gut microbiome is a significant factor in the pathogenesis and clinical presentation of PID.
• Understanding the interplay between the microbiome and the immune system in PID opens avenues for novel therapeutic approaches.
• Further research is needed to fully elucidate and harness the therapeutic potential of microbiome modulation in PID, especially for combined humoral and cellular immunodeficiencies.